Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel

Dede, D.; Gumuskaya, B.; Guler, GÜLNUR; Onat, D.; Altundag, K.; Ozisik, Y.

Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel

Atıf İçin Kopyala

Dede D. S. , Gumuskaya B., Guler G. , Onat D., Altundag K., Ozisik Y.

JOURNAL OF BUON, cilt.18, ss.57-63, 2013 (SCI İndekslerine Giren Dergi)

Cilt numarası: 18 Konu: 1
Basım Tarihi: 2013
Dergi Adı: JOURNAL OF BUON
Sayfa Sayıları: ss.57-63

Özet

Purpose: To assess the changes of biologic markers estrogen receptors (ER), progesterone receptors (PR), HER 2 and Ki-67 in locally advanced breast cancer patients after neoadjuvant chemotherapy.